Coronavirus Update: Imperial And Morningside Form Social Enterprise For COVID-19 Vaccine
Plus Updates From Daiichi And Shionogi
Executive Summary
London university ready to launch clinical trials of vaccine based on self-amplifying RNA technology shortly.